Gilles Defer

9PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthRegenerative medicine (incl. stem cells)Pharmaceutical delivery technologiesReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 05, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

|Jul 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Antoine Gavoille, Emmanuelle Leray, Romain Marignier

|Jul 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Camille Robin, Fabien Rollot, Mathilde Lefort

|May 02, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study.

Mikael Cohen, Fabien Rollot, Marc Debouverie

|Feb 20, 2025
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.

David Devos, Olivier Rascol, Wassilios G Meissner

|Feb 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.

Marie Mainguy, Romain Casey, Sandra Vukusic

Pageof 2

Frequent Collaborators

5 joint publications

Romain Casey

5 joint publications

Eric Berger

5 joint publications

Pierre M Labauge

5 joint publications

Jérôme De Sèze